Welcome to LookChem.com Sign In|Join Free

CAS

  • or

19090-89-2

Post Buying Request

19090-89-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

19090-89-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 19090-89-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,9,0,9 and 0 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 19090-89:
(7*1)+(6*9)+(5*0)+(4*9)+(3*0)+(2*8)+(1*9)=122
122 % 10 = 2
So 19090-89-2 is a valid CAS Registry Number.

19090-89-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-butylazepan-2-one

1.2 Other means of identification

Product number -
Other names 2H-Azepin-2-one,1-butylhexahydro

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:19090-89-2 SDS

19090-89-2Downstream Products

19090-89-2Relevant articles and documents

-

Marvel,Moyer

, p. 1065 (1957)

-

Composition comprising an oxygenated cholesterol and use thereof for topical treatment of diseases

-

, (2008/06/13)

The invention is directed to a pharmaceutical composition comprising an oxygenated cholesterol and a penetration-enhancing agent which is useful for topical application to the skin of a patient suffering from a proliferative skin disease characterized by geminative cells having a rapid rate of replication, e.g. psoriasis. The composition comprises an effective amount for the inhibition of germinative cell mitosis of an oxygenated cholesterol, e.g. 26-hydroxycholesterol, or a pharmaceutically effective derivative thereof e.g. an ester or ether. The invention is further directed to a method of treating a patient suffering from said skin disease comprising applying to the effected skin said therapeutic composition. The invention is also directed to the topical application of these compositions to the skin to decrease inflammation.

Central nervous system active compounds. I. The synthesis of some caprolactam derivatives substituted at N1, C2 and C3

Duong,Prager,Ward,Kerr

, p. 2651 - 2665 (2007/10/04)

-

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 19090-89-2